NEFL and Alzheimer disease: We also aimed to describe p‐tau217/NfL biomarker profiles of AD pathology and neuronal injury (e.g., low AD/low neuronal injury, high AD/high neuronal injury) in an unselected population of patients from a neuropsychiatry memory clinic.